Alternative therapies are mentioned often by participants in the workers compensation sector trying to manage injured workers' pain while shifting away from the industry's dependence on opioids — and acupuncture is the talk of the town.
More stories
Mitchell
Article
The Realization of Claims Virtualization
Five years ago, if someone mentioned “claims virtualization,” it most likely referred to an insurance carrier’s mobile application, or possibly just conjured visions of VR goggles used for high-tech simulations. These days however, the idea of virtual claims handling, or as Lexis Nexis1 defines it, “photo or video estimating in which no insurance employee physically inspects the vehicle,” has firmly taken hold with touchpoints from First Notice of Loss to Total Loss and all points in between.
Mitchell
Article
The Impact of Calibration Needs on Collision Repair
With the increasing ubiquity of Advanced Driver Assistance Systems (ADAS), comes the increasing need for systems to be properly calibrated to ensure proper functionality after a repair has taken place. In many instances, calibrations are required simply because there is damage in the general area of a particular component, even if it wasn’t directly impacted by the collision event.
Mitchell
News Release
Create Rules that Drive Accurate and Proper Repairs with Estimate Advisor
As vehicle technology continues to change, having a Compliance Tool that has the ability to create flexible and detailed rules is a must.
Auto Casualty
News Release
Mitchell Announces Simplified Implementation for ClaimIQ Liability and Injury Software
Mitchell introduces new ClaimIQ liability and injury software implementation options to increase accessibility for additional insurance carrier types.
Mitchell
News Release
Mitchell Issues 1st Quarter 2020 Industry Trends Report
Electric car sales grow but repairs remain costly; workers' compensation predictions for 2020; claims technology and the human touch.
Workers' Comp
Blog
Is there a new concern related to Gabapentin use and serious breathing problems?
In a drug safety communication from FDA Medwatch, the FDA warns about serious breathing difficulties related to the use of gabapentinoid (GabaP) medications in patients with other respiratory risk factors.1